Magnetic field activated drug delivery using thermodegradable azo-functionalised PEG-coated core-shell mesoporous silica nanoparticles.

Saint-Cricq, P; Deshayes, S; Zink, J I; Kasko, A M

Saint-Cricq, P; Deshayes, S; Zink, J I; Kasko, A M.

Afiliação

Saint-Cricq P; Department of Chemistry and Biochemistry, and California NanoSystems Institute, University of California Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
Deshayes S; Bioengineering Department, and California NanoSystems Institute University of California Los Angeles, 410 Westwood Plaza, Los Angeles, California 90095-1600, United States.
Zink JI; Department of Chemistry and Biochemistry, and California NanoSystems Institute, University of California Los Angeles, 607 Charles E. Young Drive East, Los Angeles, California 90095, United States.
Kasko AM; Bioengineering Department, and California NanoSystems Institute University of California Los Angeles, 410 Westwood Plaza, Los Angeles, California 90095-1600, United States.

Nanoscale ; 7(31): 13168-13172, 2015 Aug 21.

Article em En | MEDLINE | ID: mdl-26181577

Assuntos

Sistemas de Liberação de Medicamentos/métodos; Óxido Ferroso-Férrico/química; Polietilenoglicóis/química; Dióxido de Silício/química; Nanopartículas; Porosidade

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Polietilenoglicóis / Sistemas de Liberação de Medicamentos / Dióxido de Silício / Óxido Ferroso-Férrico Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google